Skip to main content
SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD logo

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD — Investor Relations & Filings

Ticker · 688389 ISIN · CNE100005WZ5 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 812 across all filing types
Latest filing 2019-10-16 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688389

About SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD

https://en.lifotronic.com/

SHENZHEN LIFOTRONIC TECHNOLOGY CO.,LTD. specializes in the research, development, and manufacturing of medical equipment for therapeutic and diagnostic applications. The company’s therapeutic portfolio includes negative pressure wound therapy (NPWT) systems, high-frequency chest wall oscillation devices for airway clearance, and various physical therapy and rehabilitation solutions. In the field of in-vitro diagnostics, it offers high-performance liquid chromatography (HPLC) hemoglobin analyzers for diabetes management and chemiluminescence immunoassay (CLIA) platforms. Lifotronic integrates advanced engineering with clinical requirements to provide solutions for wound care, respiratory health, and laboratory testing. The company serves a global market, focusing on technological innovation and the delivery of precise, reliable medical instruments designed to improve patient outcomes across diverse clinical settings.

Recent filings

Filing Released Lang Actions
首次公开发行股票并在科创板上市招股意向书附录（二）
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm (Zhong Lun Law Firm) regarding the initial public offering (IPO) and listing of Shenzhen Pumen Technology Co., Ltd. on the STAR Market (科创板) of the Shanghai Stock Exchange. It references relevant Chinese securities laws, regulations, and registration rules for IPOs on the STAR Market. The document includes detailed legal analysis of the issuer's qualifications, approvals, authorizations, corporate governance, financial audits, and compliance with listing requirements. It is not a financial report, earnings release, or a simple announcement but a comprehensive legal opinion supporting the IPO registration. This type of document is typically part of the IPO registration and legal due diligence process and is best classified as a Regulatory Filing (RNS) because it is a regulatory compliance document related to the IPO process, not a financial report or a proxy statement. The document is lengthy (15,000 characters) and contains substantive legal content rather than just an announcement or certification. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2019-10-16 Chinese
首次公开发行股票并在科创板上市招股意向书附录（一）
Governance Information Classification · 95% confidence The document is a detailed company charter or articles of association (章程) for Shenzhen Lifotronic Technology Co., Ltd. It includes chapters on company purpose, share issuance, shareholder rights, board and management structure, shareholder meetings, and other governance matters. It is a comprehensive governance document outlining the internal rules and organizational structure of the company. There is no indication that this is an annual report, financial statement, or announcement of voting results. It is not a proxy statement or remuneration report. The content fits the description of Governance Information (CGR), which covers the company's internal rules, board structure, and governance practices.
2019-10-16 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.